<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">ometendo</journal-id><journal-title-group><journal-title xml:lang="en">Obesity and metabolism</journal-title><trans-title-group xml:lang="ru"><trans-title>Ожирение и метаболизм</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2071-8713</issn><issn pub-type="epub">2306-5524</issn><publisher><publisher-name>Endocrinology Research Centre</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14341/omet12859</article-id><article-id custom-type="elpub" pub-id-type="custom">ometendo-12859</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОБЗОРЫ</subject></subj-group></article-categories><title-group><article-title>Possible Weight Regain Managements after Bariatric Surgery</article-title><trans-title-group xml:lang="ru"><trans-title>Possible Weight Regain Managements after Bariatric Surgery</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8081-4079</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Ardekani</surname><given-names>Mona Kamali</given-names></name><name name-style="western" xml:lang="en"><surname>Ardekani</surname><given-names>Mona Kamali</given-names></name></name-alternatives><bio xml:lang="ru"><p>Mona Kamali Ardekani, Psychiatrist</p><p>Medical Research Center</p><p>Tehran</p></bio><bio xml:lang="en"><p>Mona Kamali Ardekani, Psychiatrist</p><p>Medical Research Center</p><p>Tehran</p></bio><email xlink:type="simple">kamali.m40@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3766-0478</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Lacy</surname><given-names>Vivienne A.</given-names></name><name name-style="western" xml:lang="en"><surname>Lacy</surname><given-names>Vivienne A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Vivienne A Lacy, BSc in Biology</p><p>Department of Biology</p><p>Lubbock, Texas</p></bio><bio xml:lang="en"><p>Vivienne A. Lacy, BSc in Biology</p><p>Department of Biology</p><p>Lubbock, Texas</p></bio><email xlink:type="simple">vivienne.lacy@ttu.rdu</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3949-4939</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Eshghjoo</surname><given-names>Sahar</given-names></name><name name-style="western" xml:lang="en"><surname>Eshghjoo</surname><given-names>Sahar</given-names></name></name-alternatives><bio xml:lang="ru"><p>Sahar Eshghjoo, PhD in Biomedical sciences</p><p>Department of Microbial Pathogenesis and Immunology, College of Medicine, Health Science Center</p><p>Bryan, Texas</p></bio><bio xml:lang="en"><p>Sahar Eshghjoo, PhD in Biomedical sciences</p><p>Department of Microbial Pathogenesis and Immunology, College of Medicine, Health Science Center</p><p>Bryan, Texas</p></bio><email xlink:type="simple">sahar.eshghjo@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2705-831X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Anbara</surname><given-names>Taha</given-names></name><name name-style="western" xml:lang="en"><surname>Anbara</surname><given-names>Taha</given-names></name></name-alternatives><bio xml:lang="ru"><p>Taha Anbara, MD, General and laparoscopic surgeon</p><p>Department of Surgery</p><p>Zip code:1476919491, Iran</p></bio><bio xml:lang="en"><p>Taha Anbara, MD, General and laparoscopic surgeon</p><p>Department of Surgery</p><p>Zip code:1476919491, Iran</p></bio><email xlink:type="simple">drtahaanbara@dranbara.com</email><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Tandis Hospital</institution><country>Иран</country></aff><aff xml:lang="en"><institution>Tandis Hospital</institution><country>Islamic Republic of Iran</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>Texas Tech University</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>Texas Tech University</institution><country>United States</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru"><institution>Texas A&amp;M University</institution><country>Соединённые Штаты Америки</country></aff><aff xml:lang="en"><institution>Texas A&amp;M University</institution><country>United States</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru"><institution>Erfan Niayesh Hospital</institution><country>Иран</country></aff><aff xml:lang="en"><institution>Erfan Niayesh Hospital</institution><country>Islamic Republic of Iran</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>08</day><month>08</month><year>2022</year></pub-date><volume>19</volume><issue>2</issue><fpage>213</fpage><lpage>223</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Ardekani M.K., Lacy V.A., Eshghjoo S., Anbara T., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Ardekani M.K., Lacy V.A., Eshghjoo S., Anbara T.</copyright-holder><copyright-holder xml:lang="en">Ardekani M.K., Lacy V.A., Eshghjoo S., Anbara T.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.omet-endojournals.ru/jour/article/view/12859">https://www.omet-endojournals.ru/jour/article/view/12859</self-uri><abstract><p>Obesity is an uprising trend across the world resulting in huge costs for healthcare systems and declines in the quality of life in patients. Bariatric surgery is one of the most effective approaches to weight loss. Although bariatric surgery can be considered as a minimally invasive approach it has a series of complications such as weight regain 1 to 4 years after surgery. Nonetheless, most patients achieve sufficient weight loss, but the other subjects with supervised strategies would be able to manage food intake and change problematic lifestyles to continue the weight loss process. In this review article, we aim to gather valuable interventions performed and reported by researchers to manage weight regain in bariatric patients. Weight regain is a multi-factorial condition owing to hormonal imbalances, nutritional deficiencies, physical inactivity, mental health disorders, problematic dietary behaviors, medical issues such as thyroid, adrenal, kidney, or heart problems, taking new medications, diabetes relapse, and pregnancy, as well as anatomic and surgical factors. Therefore, its remission needs interdisciplinary approaches.</p></abstract><trans-abstract xml:lang="ru"><p>Obesity is an uprising trend across the world resulting in huge costs for healthcare systems and declines in the quality of life in patients. Bariatric surgery is one of the most effective approaches to weight loss. Although bariatric surgery can be considered as a minimally invasive approach it has a series of complications such as weight regain 1 to 4 years after surgery. Nonetheless, most patients achieve sufficient weight loss, but the other subjects with supervised strategies would be able to manage food intake and change problematic lifestyles to continue the weight loss process. In this review article, we aim to gather valuable interventions performed and reported by researchers to manage weight regain in bariatric patients. Weight regain is a multi-factorial condition owing to hormonal imbalances, nutritional deficiencies, physical inactivity, mental health disorders, problematic dietary behaviors, medical issues such as thyroid, adrenal, kidney, or heart problems, taking new medications, diabetes relapse, and pregnancy, as well as anatomic and surgical factors. Therefore, its remission needs interdisciplinary approaches.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Bariatric surgery</kwd><kwd>obesity</kwd><kwd>weight regain</kwd><kwd>preventive medicine</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Bariatric surgery</kwd><kwd>obesity</kwd><kwd>weight regain</kwd><kwd>preventive medicine</kwd></kwd-group></article-meta></front><body><sec><title>INTRODUCTION</title><p>Bariatric surgery is one of the final surgical methods which can achieve weight loss (WL), treat obesity-related comorbidities, and enhance the quality of life by improving cardiovascular disorders, metabolic status, and biochemical parameters [<xref ref-type="bibr" rid="cit1">1</xref>], thereby decreasing the inflammatory markers and increasing hematological markers [<xref ref-type="bibr" rid="cit2">2</xref>][<xref ref-type="bibr" rid="cit3">3</xref>]. Despite all the benefits of bariatric surgery, some individuals are not satisfied by their body sizes and weight, and some others experience weight regain (WR) in a long-term follow-up period. While WR has a series of undesirable medical and psychological consequences, which might occur following bariatric surgery to different extents at variable interval times, the causes for WR are multifactorial, including patient- and procedure-specific factors, and can vary from case to case.</p><p>We used three main databases in clinical research including Google Scholar, PubMed, and Web of Science to collect relevant data. Keywords for structural searches were divided into three vertices including 1) Bariatric surgery (RYGB, Laparoscopic sleeve surgery, robotic sleeve gastrectomy, weight loss surgery, obesity surgery, and bariatric surgery), 2) Management (weight regain management, preventive medicine, post-operative strategies, hormonal treatment, nutritional recommendation, dietary behavior, physical activity, pharmacotherapy), and 3) Weight loss (Insufficient weight loss, weight regain, weight gain, weight, higher BMI, overweight and obesity) from 2015 to 2022 research articles.</p></sec><sec><title>DEFINITIONS OF INSUFFICIENT WEIGHT LOSS AND WEIGHT REGAIN</title><p>Several studies described a range of definitions for WR following bariatric surgery. The lack of standard protocol for the management of WR, consensus statements, and guidelines leads to poor reporting and understanding of the significance of WR after bariatric surgery. The most common definition is a 25% increase in excessive weight compared to the nadir weight after bariatric surgery. Furthermore, there are some other definitions for WR such as gaining more than 15% or 10 kg from nadir weight [<xref ref-type="bibr" rid="cit4">4</xref>], gaining more than 10% WR of pre-surgery weight [<xref ref-type="bibr" rid="cit5">5</xref>], and more than 5 BMI kg/m2 points from nadir weight [<xref ref-type="bibr" rid="cit6">6</xref>]. On the other hand, insufficient weight loss is defined as excess weight loss percentage (EWL%) of &lt; 50% at 18 months after bariatric surgery. In addition, WR is defined as progressive regaining of weight that occurs after achievement of an initial successful weight loss (defined as EWL&gt;50%) [<xref ref-type="bibr" rid="cit7">7</xref>].</p></sec><sec><title>PREVALENCE OF WR AND INSUFFICIENT WEIGHT LOSS AFTER BARIATRIC PROCEDURES</title><p>Bariatric patients experience satisfactory weight loss even after 2 years of the procedure, but the tragedy begins when patients have no idea and why they go on weight. In a study for this purpose, WR rates ranged from 44–87% among 1406 Roux-en-Y Gastric Bypass (RYGB) subjects 5 years after the surgery (5). Another research reported that 5.7% of individuals who underwent sleeve gastrectomy (SG) experienced WR at 2 years [<xref ref-type="bibr" rid="cit8">8</xref>], 39.5% at 5 years [<xref ref-type="bibr" rid="cit9">9</xref>], and 76% over 2 to 6 years of follow-up periods [<xref ref-type="bibr" rid="cit8">8</xref>]. There is a tremendous number of reports on WR after RYGB, including, 17.1% at 2 years [<xref ref-type="bibr" rid="cit10">10</xref>], 22.5% at 3 years [<xref ref-type="bibr" rid="cit5">5</xref>], 14.6%–26.8% at 5 years [<xref ref-type="bibr" rid="cit5">5</xref>][<xref ref-type="bibr" rid="cit11">11</xref>], but this type of procedure seems to have a higher range of WR in patients compared to other types of bariatric surgery. Laparoscopic adjustable gastric banding (LAGB), on the other side, had a lesser range of WR in subjects, and just 1.4% of people who underwent LAGB reported WR in 3 to 7 years of the follow-up period [<xref ref-type="bibr" rid="cit12">12</xref>]. Even in a long-term period, just 38% of subjects complained WR at 10 years after LAGB [<xref ref-type="bibr" rid="cit13">13</xref>]. It can be concluded that around 40% of people who underwent bariatric surgery experienced WR following 5 years of surgery. Figure 1 presents the prevalence of WR of patients with various types of bariatric surgery including LAGB, LSG, and RYGB between 2 and 10 years following bariatric surgery.</p><fig id="fig-1"><caption><p>Figure 1. The prevalence of weight regain in different types of bariatric surgery between 2 and 10 years after the surgery based on various recently published reports (5,8–13,85). LAGB: Laparoscopic gastric band; LSG: Laparoscopic sleeve gastrectomy; and RYGB: Roux en Y gastric bypass. around 40% of individuals experienced weight regain following 5 years of bariatric surgery.</p></caption><graphic xlink:href="ometendo-19-2-g001.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/ometendo/2022/2/m8YbHYR6llXqIJfwixFVrybZ0coE9G8hP8fLPWJf.jpeg</uri></graphic></fig></sec><sec><title>THE PRINCIPAL REASONS OF WR AFTER BARIATRIC SURGERY</title><p>Considering that, the causes of WR following bariatric surgery are multifactorial, they can be divided into two types including physiological and anatomical factors. The first one is caused by hormonal parameters, the gut-brain axis, psychiatric conditions, eating disorders, and unstable lifestyles such as dietary non-compliance and physical inactivity. Those factors are directly involved in loss of control and increase in the food intake. Figure 2 presents more sub-themes involved in WR after bariatric surgery. Anatomical causes consist of an enlargement of the gastric pouch or gastrogastric fistula (GG fistula; an axis from the gastric pouch to the gastric remnant, which is a rare but important complication of RYGB), anatomic surgical failure, and gastrointestinal anatomy [<xref ref-type="bibr" rid="cit14">14</xref>]. Considering these crucial ­etiologies is a principal step to establishing a proper protocol for the management of WR following bariatric surgery. Figure 3 demonstrates a brief map of the multidisciplinary approaches involved in WR management.</p><fig id="fig-2"><caption><p>Figure 2. Schematic map of correlations between factors involved in loss of control in bariatric surgery patients in long-term follow-up period.</p></caption><graphic xlink:href="ometendo-19-2-g002.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/ometendo/2022/2/NIdTPIMjbrhtKLk6ztrHjhXLkaCiSVsFHNtLo563.jpeg</uri></graphic></fig><fig id="fig-3"><caption><p>Figure 3. Algorithm of post-operative weight management with multiple approaches. APC: argon plasma coagulation; ESD: endoscopic submucosal dissection.</p></caption><graphic xlink:href="ometendo-19-2-g003.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/ometendo/2022/2/5TviOMMExyakam6o4sMzmfCWkfs3eE4e8yQgkkQ8.jpeg</uri></graphic></fig></sec><sec><title>Hormonal imbalance</title><p>Bariatric patients experience a series of improvements in hormonal and other health parameters following procedure which results in weight reduction and risen quality of life. For instance, Peptide YY, which is released by the L-cells of the gastrointestinal tract to suppress appetite after meals, is dropped down in individuals who experience WR [<xref ref-type="bibr" rid="cit15">15</xref>]. Increased ghrelin is another hormonal imbalance that can be seen in this population after bariatric surgery [<xref ref-type="bibr" rid="cit16">16</xref>][<xref ref-type="bibr" rid="cit17">17</xref>]. In addition, a reactive reduction in glucose levels of blood, which is dependent on altered GI hormones and insulin secretion, is a key point to skyrocket the transition of micronutrients into the jejunum leading to WR in bariatric patients [<xref ref-type="bibr" rid="cit18">18</xref>]. The fasting insulin is another parameter that might be associated with WR after bariatric surgery [<xref ref-type="bibr" rid="cit19">19</xref>]. It occurs when lower blood sugar levels caused by significant insulin secretion after food intake may restore appetite and lead to grazing or snacking which results in WR in subjects [<xref ref-type="bibr" rid="cit20">20</xref>].</p><p>Leptin which is released by fat cells is responsible for the reduction in appetite. Although bariatric surgery has a positive impact on leptin regulation, patients with WR demonstrated increased levels of leptin [<xref ref-type="bibr" rid="cit17">17</xref>][<xref ref-type="bibr" rid="cit21">21</xref>][<xref ref-type="bibr" rid="cit22">22</xref>]. Eventually, decreased serotonin levels can be seen postoperatively in patients with WR [<xref ref-type="bibr" rid="cit17">17</xref>]. While, hormonal analysis in bariatric subjects with weight loss illustrated opposite results in which dropped ghrelin, increased Peptide YY, glucagon-like peptide 1 (GLP-1), leptin, cholecystokinin, pancreatic polypeptide, and uroguanylin (It regulates electrolyte and water transport in intestinal and renal epithelia) and blood sugar levels were reported in previously published studies [<xref ref-type="bibr" rid="cit1">1</xref>].</p><p>To suppress ghrelin secretion, which is known as the hunger hormone, obesity experts can encourage patients to avoid sweetened drinks including fruit drinks, sports (energy) drinks, sweetened waters, regular soda (not sugar-free ones), coffee and tea beverages with added sugars and high-fructose corn syrup, which can impair ghrelin response after food-intake to receive the strong signal to stop eating in the hypothalamus [<xref ref-type="bibr" rid="cit23">23</xref>][<xref ref-type="bibr" rid="cit24">24</xref>].</p><p>When it comes to insulin, patients must have a low-carbohydrate diet [<xref ref-type="bibr" rid="cit25">25</xref>], fill up on protein, omega-3 fats diet found in fatty fish and avoid or minimize the amounts of fructose and sucrose which promote insulin resistance and increase insulin levels [<xref ref-type="bibr" rid="cit24">24</xref>][<xref ref-type="bibr" rid="cit26">26</xref>]. Furthermore, people suffering from insulin resistance demonstrate lower amounts of magnesium and in this case, magnesium supplements [<xref ref-type="bibr" rid="cit27">27</xref>][<xref ref-type="bibr" rid="cit28">28</xref>] and green tea [<xref ref-type="bibr" rid="cit29">29</xref>][<xref ref-type="bibr" rid="cit30">30</xref>] can improve insulin sensitivity.</p><p>Leptin and cholecystokinin play a major role in regulating appetite and preventing overeating. On the other hand, chronically enhanced insulin levels and inflammation in the hypothalamus are mainly responsible for leptin resistance. To improve insulin sensitivity and increase cholecystokinin, subjects with WR must limit inflammatory foods such as unsaturated fats, junk foods, refined carbohydrates, fried foods, sugar-sweetened beverages, processed meats, and sugary drinks and on the other side, healthy fat [<xref ref-type="bibr" rid="cit31">31</xref>], anti-inflammatory foods such as berries, fatty fish, broccoli, avocados, green tea, mushrooms grapes, turmeric, extra virgin olive oil, dark chocolate and cocoa, tomatoes, cherries, peppers which are full of vitamin C and antioxidants can be efficient ingredients for the improvement of leptin levels [<xref ref-type="bibr" rid="cit32">32</xref>]. In addition, moderate exercise, sufficient sleep at night, and taking the alpha-lipoic acid supplement and fish oil are other suggestions for the reduction in appetite and improving leptin sensitivity [<xref ref-type="bibr" rid="cit33">33</xref>].</p><p>Lower serotonin levels can be seen in people with WR after bariatric surgery [<xref ref-type="bibr" rid="cit17">17</xref>] which is required to be addressed by obesity medicine experts in long-time follow-up visits. Some dietary supplements namely pure tryptophan supplements [<xref ref-type="bibr" rid="cit34">34</xref>], S-adenosyl-L-methionine (must not take with any other supplements or serotonin stimulating medications) [<xref ref-type="bibr" rid="cit35">35</xref>], 5-Hydroxy-L-tryptophan content [<xref ref-type="bibr" rid="cit36">36</xref>], St. John’s wort (not recommended for long-term use) [<xref ref-type="bibr" rid="cit37">37</xref>], and probiotics [<xref ref-type="bibr" rid="cit38">38</xref>] can be prescribed to operate the serotonin production and release by declining cortisol and enhancing tryptophan levels [<xref ref-type="bibr" rid="cit39">39</xref>]. There are also some other ideas for raising serotonin and reducing cortisol in patients with WR including a series of snacks such as salmon with brown rice, whole-wheat bread with turkey or cheese, plums or pineapple with a cracker, oatmeal with 30g of nuts, pretzel sticks with peanut butter and 200 ml of milk [<xref ref-type="bibr" rid="cit40">40</xref>][<xref ref-type="bibr" rid="cit41">41</xref>], as well as aerobic exercises such as bicycling, brisk walking, and swimming, practicing meditation, spending 15 to 30 minutes in the sunshine each day [<xref ref-type="bibr" rid="cit39">39</xref>][<xref ref-type="bibr" rid="cit42">42</xref>].</p><p>Peptide YY plays a major role in lowering food intake and the risk of obesity, and as has been mentioned previously, people with WR illustrated a reduction in this hormone in a long-term period after bariatric surgery [<xref ref-type="bibr" rid="cit15">15</xref>]. In order for peptide YY to be risen and reduce neuropeptide Y in this population, experts suggest ingestion of fibers [<xref ref-type="bibr" rid="cit43">43</xref>], protein-rich diets from animal or plant sources [<xref ref-type="bibr" rid="cit44">44</xref>], soluble probiotics [<xref ref-type="bibr" rid="cit45">45</xref>], and as well as low carbohydrate diets [<xref ref-type="bibr" rid="cit46">46</xref>][<xref ref-type="bibr" rid="cit47">47</xref>].</p><p>Furthermore, subjects who had high-protein foods such as fish, whey protein, and yogurt, anti-inflammation diet, leafy green meals including spinach and kale and took probiotics under supervision of physician lost more weight than the control group and had higher GLP-1 levels compared to the rest of patients [<xref ref-type="bibr" rid="cit48">48</xref>][<xref ref-type="bibr" rid="cit49">49</xref>].</p><p>Considering the environmental influences on estrogen levels in women, most researchers suggest nutrition and lifestyle strategies to manage estrogen levels and reduce insulin resistance. Eating plenty of fiber-rich diets, flax seeds, cruciferous vegetables such as arugula, bok choy, broccoli, brussels sprouts, and cabbage can be helpful to reach a normal balance of estrogen in women [<xref ref-type="bibr" rid="cit50">50</xref>][<xref ref-type="bibr" rid="cit51">51</xref>].</p></sec><sec><title>NUTRITIONAL PROBLEMS</title><p>Although the anatomic and physiological improvements result in a smaller gastric capacity, diminished hunger, and increased satiety which reduce calorie intake following bariatric surgery, caloric intake slightly enhances over time which contributes to postoperative WR. Moreover, consumption of high-calorie meals and beverages contributes to the higher caloric intake resulting in WR. Strong connections between the prevalence of WR and consumption of large amounts of food lately, eating large quantities of high-fat dishes, and eating out have been reported by researchers [<xref ref-type="bibr" rid="cit52">52</xref>]. In another survey, equally, 23% of RYGB patients illustrated dietary non-adherence and a continuation of pre-surgical eating patterns, leading to suboptimal weight loss and WR [<xref ref-type="bibr" rid="cit53">53</xref>]. These studies presented the importance of caloric intake and diet quality as leading factors for WR following bariatric surgery, and also concluded the importance of food indiscretion, measuring and documenting the diet quality among bariatric patients [<xref ref-type="bibr" rid="cit54">54</xref>] which alongside WR, patients may have some other challenging conditions in various organs owing to malnutrition in some specific ingredients such as protein malnutrition or iron deficiency (Figure 4), demonstrating the necessity of physical assessments in patients with WR after bariatric surgery. For instance, a survey on 100 patients revealed that poor dietary habits including consumption of excessive calories, snacks, sweets, oils, and fatty foods were statistically higher in patients with WR [<xref ref-type="bibr" rid="cit55">55</xref>]. This highlights the importance of appropriate nutritional counseling and nutritional follow-up for long-term weight maintenance [<xref ref-type="bibr" rid="cit55">55</xref>]. In line with this claim, studies showed that among RYGB patients 60% of WR subjects never maintained follow-up with appropriate nutritional consultants after the operation which might be associated with WR [<xref ref-type="bibr" rid="cit56">56</xref>]. Based on studies, the optimal diet is high protein meals (1.0 to 1.5 g/kg per day), low glycemic index, low-fat contents, and high fiber foods including poultry, fish, lean, meats, eggs, low-fat dairy. Legumes, fruits, vegetables, and whole grains. At least 5 servings of fruits and vegetables per day are highly recommended. Bariatric patients must avoid sugars and refined carbohydrates to prevent hypoglycemia that results in dumping syndrome, one of the crucial risk factors of WR.</p><fig id="fig-4"><caption><p>Figure 4. Organ complications after bariatric surgery caused by nutritional challenges in patients with weight regain.</p></caption><graphic xlink:href="ometendo-19-2-g004.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/ometendo/2022/2/AE2wbuUSCE6ff5YWKdWXDvhBz42pbTHPuPGkudNn.jpeg</uri></graphic></fig></sec><sec><title>PHYSICAL INACTIVITY</title><p>Physical activity is one of the most important factors that can prevent WR in patients after bariatric surgery. Only 10–24% of bariatric surgery patients met the guidelines regarding minimal physical activity for health promotion [<xref ref-type="bibr" rid="cit57">57</xref>]. A meta-analysis of 14 studies and a literature review of 19 studies concluded that post-operative physical activity was significantly associated with greater weight loss among bariatric patients [<xref ref-type="bibr" rid="cit58">58</xref>]. In another survey on 100 patients with obesity following RYGB, among those who had supervised exercise the rate of WR was less compared to those who had sedentary behaviors [<xref ref-type="bibr" rid="cit55">55</xref>]. Nevertheless, there are several barriers to having daily exercise among those individuals such as feeling self-conscious lack of proximity to a gym/park, or health concerns, which should be identified and addressed by professional experts during follow-up visits [<xref ref-type="bibr" rid="cit58">58</xref>]. Such findings highlight the importance of measuring and documenting physical activity levels after bariatric surgery [<xref ref-type="bibr" rid="cit35">35</xref>].</p><p>Therefore, physical inactivity, which is defined as ‘any waking habit performed while in a sitting or reclining posture that needs very low energy expenditure’, represents a risk factor for WR. Lack of adequate exercise during the post-bariatric period is strongly correlated with an enhanced risk of obesity and its sequelae [<xref ref-type="bibr" rid="cit58">58</xref>]. Some other researchers believe that bariatric candidates with higher BMIs are at high risk for sedentary behaviors [<xref ref-type="bibr" rid="cit59">59</xref>]. In this report, they revealed that about 30% of those candidates’ sedentary time was spent watching television, presenting that this is a crucial cause of physical inactivity and must be taken into account for patient counseling [<xref ref-type="bibr" rid="cit59">59</xref>]. Enormous studies are suggesting that 80 min of (it includes 20 min for warm-up and cool-down) supervised strength training, aerobic and stretching exercise, and endurance activities for 3 weeks can be particularly effective at reducing visceral adipose tissue (VAT) [<xref ref-type="bibr" rid="cit60">60</xref>], a fat accumulation area that is strongly linked to T2D and hepatic insulin resistance. On the other side, 120  min of supervised aerobic exercise for 6 to 10 months and starting 1 to 3 months after surgery can strongly prevent WR in a long-term period following bariatric surgery [61–63].</p></sec><sec><title>MENTAL HEALTH AND PSYCHOLOGICAL STATUS</title><p>Psychological status before surgery is associated with weight loss following bariatric surgery, which represents pre-operative psychological evaluation for the candidates. Psychological factors would play an intervening role in weight loss by undermining motivation, problematic dietary behavior, inadequate exercise, and other unhealthy behaviors crucial for successful weight loss [<xref ref-type="bibr" rid="cit64">64</xref>]. Based on a study on 60 adults RYGB or LAGB subjects, around 73% had single or multiple psychiatric diagnoses, and 47.5% did not achieve their target weight, and 29.5% regained weight after 1 year [<xref ref-type="bibr" rid="cit64">64</xref>]. In addition, individuals with more than 2 psychiatric conditions were 6 times more at risk of either stopping weight loss or regaining weight compared to those with no or single psychiatric diagnosis [<xref ref-type="bibr" rid="cit64">64</xref>]. There are various reports, suggesting the correlation between postoperative depressive disorders and poorer weight loss [<xref ref-type="bibr" rid="cit65">65</xref>][<xref ref-type="bibr" rid="cit66">66</xref>]; however, the directionality of the relationship and rationale mechanisms remain unclear [<xref ref-type="bibr" rid="cit66">66</xref>]. The models predicting depressive symptoms, anxiety symptoms, and physical health-related quality of life were not significant in bariatric patients. Frequent psychological screenings for depression, anxiety, and other neurological disorders might be required in long-term follow-up visits. On the other side, psychotropic and anti-depressant medications are involved in WR, while several studies revealed that anti-depressant medications have negative [<xref ref-type="bibr" rid="cit67">67</xref>] or no [<xref ref-type="bibr" rid="cit68">68</xref>][<xref ref-type="bibr" rid="cit69">69</xref>] impacts on weight loss in bariatric surgery patients. Therefore, strong communication between obesity medicine experts and mental health physicians is a necessary step to manage weight loss to choose the least weight-promoting or weight-neutral agents.</p></sec><sec><title>UNHEALTHY DIETARY BEHAVIORS</title><p>Dietary behaviors which play a major role in WR must be evaluated after bariatric surgery in patients. Most of the people suffering from weight plateau complain about grazing, but they may have other dietary behaviors rather than bulimia nervosa or grazing. The most principal dietary problems can be divided into 13 groups including erratic eating, meal skipping or inappropriate portions, unhealthy ingredients selections, alcohol use, insufficient protein, and fiber intake, drinking fluids with meals, grazing, binge eating, night eating syndrome, post-surgical eating avoidance disorder, soft-food syndrome, and eating disorders such as bulimia nervosa and anorexia nervosa [<xref ref-type="bibr" rid="cit70">70</xref>]. For instance, alcohol use disorder leads to binge eating and finally results in high-calorie intake in subjects after bariatric surgery. When patients are diagnosed with problematic eating behaviors, obesity medicine experts would determine the exact type of dietary behavior then all those mentioned interventions can be considered to solve the problem. There are some efficient intervention approaches following bariatric surgery for dietary behaviors involved in WR that can be found in Table 1 [<xref ref-type="bibr" rid="cit70">70</xref>].</p><table-wrap id="table-1"><caption><p>Table 1. Problematic eating behaviors associated with weight regain and intervention approaches following bariatric surgery [70]</p></caption><table><tbody><tr><td>Eating Behavior</td><td>Problem</td><td>Intervention</td></tr><tr><td>Erratic eating</td><td>Inconsistent/unplanned eating schedule</td><td>Preplan approximate timing and appropriate spacing of meals throughout the day based on daily schedule</td></tr><tr><td>Meal skipping</td><td>Not eating for an extended time period leading to subsequent hunger and overeating</td><td>Plan meals ahead of time; create a shopping list to ensure selected food and appropriate amounts are available to prepare these meals</td></tr><tr><td>Unhealthy food and beverage selections</td><td>Frequent intake of high-calorie/processed meals and snacks including fast food/take-out, fried food, concentrated sweets, and refined carbohydrates; calorie-rich beverages such as soda and juices</td><td>Education on balanced meal preparation containing protein and fiber-rich sources to help optimize satiety; encourage cooking classes and/or online cooking resources</td></tr><tr><td>Nibbling/Grazing</td><td>Continuous/repetitive and unplanned eating of modest portions of food throughout the day; often associated with previous binge-eating behaviors; leads to excessive cumulative energy intake</td><td>Avoidance of skipping meals; appropriate meal portion sizes (1/2–1 cup). Identify triggers including stress, boredom, and emotional factors or engaging in other activities such as watching television</td></tr><tr><td>Night eating</td><td>Consuming more calories before sleep favors positive energy balance and weight gain</td><td>Schedule time for meals during the day;self-monitor using food journal</td></tr><tr><td>Inappropriate portions</td><td>Portion sizes beyond the feeling of fullness resulting in discomfort</td><td>Weigh and measure foods, use smaller plates and utensils, and limit volume to 1 cup of food per meal</td></tr><tr><td>Alcohol use</td><td>Excess nonnutritive calories; promotes increased hunger, food cravings, and compromises judgment regarding proper food selection</td><td>Avoid or limit alcohol consumption; consider referral to the treatment program if unable to control behavior</td></tr><tr><td>Insufficient protein and fiber intake</td><td>Protein and fiber promote optimal satiation; protein-rich foods optimize muscle integrity and energy metabolism</td><td>Education on quality sources of protein and fiber; assist with meal planning to achieve appropriate intake</td></tr><tr><td>Drinking fluids with meals</td><td>Potential enlargement of the gastric pouch and outlet with repeated behavior; leads to rapid emptying of the stomach</td><td>Delay fluid intake at least 30 minutes after consuming solid food</td></tr></tbody></table></table-wrap></sec><sec><title>MEDICAL ISSUES AND PHARMACOTHERAPY</title><p>In some patients, WR occurred due to some medical issues such as thyroid, adrenal, kidney, or heart problems, taking new medications, diabetes relapse, and pregnancy which can be addressed by proper strategies to prevent WR or reduce its progression.</p><p>Pharmacotherapy can significantly delay the progression of rapid WR as well as decline its occurrence. Nevertheless, pharmacotherapy approaches remain limited in scope for bariatric subjects due to a lack of formal guidelines and recommendations on anti-obesity medication use after bariatric surgery. Moreover, it needs obesity medicine specialists in bariatric surgery centers to support patients, which poses limitations on anti-obesity medication use. Figure 5 illustrates the features of an ideal bariatric surgery center with multidisciplinary wards for clinical and surgical assessments of patients with WR. On the other side, the lack of familiarity of bariatric surgeons with these medications and the rapid evolution of this medical field is another crucial obstacle in the way of pharmacotherapy approaches [<xref ref-type="bibr" rid="cit71">71</xref>].</p><fig id="fig-5"><caption><p>Figure 5. A brief look into an ideal bariatric surgery center with all required multidisciplinary assessments for management of weight regain after surgery.</p></caption><graphic xlink:href="ometendo-19-2-g005.jpeg"><uri content-type="original_file">https://cdn.elpub.ru/assets/journals/ometendo/2022/2/kkjpwz6mNuhr0hhe3vShiSiaqilVqmA6TJsj45hp.jpeg</uri></graphic></fig></sec><sec><title>ANATOMIC AND SURGICAL FACTORS</title><p>When it comes to anatomical factors involved in WR, a GG fistula formation occurs between the gastric pouch and the excluded stomach and its incidence rate is 1% among RYGB patients, causing weight plateau and recurrence of T2D [<xref ref-type="bibr" rid="cit72">72</xref>]. Other potential anatomical factors contributing to WR after RYGB are distention of the gastric pouch and dilation of the gastrojejunal stoma which may develop over time [<xref ref-type="bibr" rid="cit73">73</xref>]. An upper GI should be considered for WR after vertical sleeve gastrectomy as well, mainly because the dilation of the sleeve has been strongly connected to WR in subjects after bariatric surgery [<xref ref-type="bibr" rid="cit74">74</xref>].</p><p>Sclerotherapy is another surgical approach in patients with WR after RYGB which is injection of sodium morrhuate around the gastrojejunal anastomosis using an endoscopic needle to reduce its aperture and tissue compliance [<xref ref-type="bibr" rid="cit75">75</xref>]. The repair of a GG fistula, when identified on upper GI or endoscopy, is one of the most widely accepted surgical interventions for WR prevention among surgeons [<xref ref-type="bibr" rid="cit76">76</xref>]. In addition, an enlarged gastric pouch and dilated stoma are potential anatomical issues that might be considered endoscopically or laparoscopically after bariatric surgery, with good short-term weight loss outcomes but variable long-term results. The growing problem of WR after bariatric surgery has prompted the evaluation of different revisional surgeries that could be addressed even when there are no anatomic abnormalities identified in the primary procedure. Procedures such as endoscopic revisions that reduce gastric pouch size and diameter of the gastrojejunal anastomosis, the conversion of vertical sleeve gastrectomy to a gastric bypass, single anastomosis duodenoilieal (SADI) bypass, and distalization of the jejunojejunostomy for a gastric bypass, are employed to increase or add a malabsorptive component to the original procedure [<xref ref-type="bibr" rid="cit76">76</xref>][<xref ref-type="bibr" rid="cit77">77</xref>]. When considering a revision for WR after vertical sleeve gastrectomy, patients who also have acid reflux disease are good candidates for gastric bypass; but the SADI procedure provides superior weight loss to the conversion to gastric bypass for those who would be converted for WR alone [<xref ref-type="bibr" rid="cit78">78</xref>]. In this procedure, the duodenum is divided 3 cm distal to the pylorus; the small bowel is measured backward from the ileocecal valve to a length of 150 to 300 cm, where it is linked to the duodenum. Because the surgical complications and malnutrition rates of this approach are like conversion to gastric bypass, the SADI may become the procedure of choice to treat inadequate weight loss among patients following vertical sleeve gastrectomy.</p></sec><sec><title>OTHER PREDICTOR FACTORS OF WEIGHT REGAIN IN BARIATRIC SURGERY PATIENTS</title><p>Detection of the preoperative predictors of WR post-bariatric surgery can facilitate identifying the candidates at risk for WR. The obesity specialists can then offer such patients appropriate resources and counseling. About age and gender, reports seem to be controversial. Some small studies have been done in this matter and claimed that older age is a potential preoperative predictor of WR [<xref ref-type="bibr" rid="cit79">79</xref>]. While in another study, younger subjects were more likely to have WR after RYGB [<xref ref-type="bibr" rid="cit10">10</xref>]. However, there are not enough shreds of evidence on SG patients but in our previous research, excessive BMI loss among older ages was significantly lower than younger groups [<xref ref-type="bibr" rid="cit80">80</xref>]. Mental health, duration since surgery, preoperative BMI, and comorbidities such as T2D, hypertension, and low LDL are major factors involved in WR which mentioned their mechanisms and management approaches in previous sections. As far as psychological factor is concern, 27.1% of the variance of the WR is due to “locus of control, “present fatalist”, and “positive past” [<xref ref-type="bibr" rid="cit81">81</xref>]. In another study, analysis revealed that, initial age, waist circumference, type 2 diabetes, and total weight loss at primary months were associated with either 1-year or 3-year weight loss. Furthermore, total weight loss at 3 months was a predictor for 3-year WR after SG [<xref ref-type="bibr" rid="cit82">82</xref>]. Some other lifestyle factors such as life satisfaction, conscientiousness, positive affect, and regular exercise were positively associated with weight loss 12 to 15 years after bariatric surgery [<xref ref-type="bibr" rid="cit83">83</xref>]. Considering those possible strategies (Summary of possible interventions are presented in table 2) with clear vision in predictor factors of WR may help obesity medicine experts to be able to support patients efficiently, since Smith et al., believe that the six months post-operative period may be a crucial window for implementing interventions to alight WR [<xref ref-type="bibr" rid="cit84">84</xref>].</p><table-wrap id="table-2"><caption><p>Table 2. Weight regain management in patients after bariatric surgery.</p></caption><table><tbody><tr><td>Involved factors</td><td>Clinical reasons/ Unhealthy Habits</td><td>Possible treatments</td><td>Sources</td></tr><tr><td>Hormonal changes</td><td>↓ Peptide YY</td><td>Protein/fiber-rich diets, soluble probiotics, and low carbohydrate diets</td><td>[43–47]</td></tr><tr><td>↑ Neuropeptide Y</td></tr><tr><td>↑ Ghrelin</td><td>Avoid sweetened drinks</td><td>[23][24]</td></tr><tr><td>↑ Insulin</td><td>Fill up on protein, low-carbohydrate diet, avoid or minimize the amounts of fructose and sucrose</td><td>[24–26]</td></tr><tr><td>↓ Blood sugar levels</td></tr><tr><td>Insulin resistance</td><td>Magnesium supplements, and green tea</td><td>[27–30]</td></tr><tr><td>↓ Leptin</td><td>Limit inflammatory foods such as unsaturated fats, junk foods, refined carbohydrates, fried foods, sugar-sweetened beverages, processed meats, and sugary drinks</td><td>[32]</td></tr><tr><td>↓ Cholecystokinin</td></tr><tr><td>↓ GLP-1</td><td>High-protein foods, anti-inflammation diet, leafy green meals, and probiotics</td><td>[48, 49]</td></tr><tr><td>↓ Serotonin</td><td>↑ Cortisol</td><td>Tryptophan supplements, S-adenosyl-L-methionine, 5-Hydroxy-L-tryptophan content, St. John’s wort, and probiotics, as well as aerobic exercises.</td><td>[34–37][39][42]</td></tr><tr><td>↓ Tryptophan</td></tr><tr><td>Nutritional challenges</td><td>Poor dietary habits</td><td>Excessive calories</td><td>Appropriate nutritional counseling and physical/hormonal assessmentfollow-ups.5 servings of fruits and vegetables per day</td><td>[55][56]</td></tr><tr><td>Snacks</td></tr><tr><td>Sweets</td></tr><tr><td>Oils</td></tr><tr><td>Fatty foods</td></tr><tr><td>Physical inactivity</td><td>Sedentary behaviors and lack of adequate exercise during the post-bariatric period</td><td>80 minutes supervised strength training, aerobic and stretching exercise, and endurance activities for 3 weeks</td><td>[60]</td></tr><tr><td>Mental health</td><td>Undermining motivation, problematic, inadequate exercise, and other unhealthy behaviors</td><td>Frequent psychological screenings, avoid anti-depressant medications</td><td>[67]</td></tr><tr><td>Dietary behavior</td><td>Unhealthy ingredients selections, alcohol use, insufficient protein, and fiber intake, grazing, binge eating, night eating syndrome, and post-surgical eating avoidance disorder,</td><td>Obesity medicine experts should determine the type of dietary behavior (Those intervention approaches were presented in table 1)</td><td>[70]</td></tr><tr><td>Anatomical factors</td><td>GG fistula formation, distention of the gastric pouch and dilation of the gastrojejunal stoma</td><td>Repair of a GG fistula, single anastomosis duodenoilieal and other endoscopic revisional surgeries</td><td>[76][77]</td></tr></tbody></table></table-wrap></sec><sec><title>CONCLUSION</title><p>After bariatric surgery, the threat against WR will not completely be eliminated. The follow-up team should extensively have clinical assessments on patients to make sure that the predictor factors of WR are in control. For those patients who experience WR, the above-mentioned interventions should be considered.</p></sec><sec><title>ADDITIONAL INFORMATION</title><p>Funding. No funding.</p><p>Conflict of interest. The authors declare no obvious and potential conflicts of interest related to the content of this article.</p><p>Contribution of authors. MKA and SE wrote the draft and performed the analysis and TA designed the study and supervised the results in all stages. All authors read and approved the final version of the manuscript before publication, agreed to be responsible for all aspects of the work, implying proper examination and resolution of issues relating to the accuracy or integrity of any part of the work.</p><p>Acknowledgment. We appreciate all who helped us to exert this study, especially Mr. Hamidreza Goudarzi for his great support for data collection.</p></sec></body><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Kheirvari M, Dadkhah Nikroo N, Jaafarinejad H, et al. The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. Heliyon. 2020;6(2):e03496. doi: https://doi.org/10.1016/j.heliyon.2020.e03496</mixed-citation><mixed-citation xml:lang="en">Kheirvari M, Dadkhah Nikroo N, Jaafarinejad H, et al. The advantages and disadvantages of sleeve gastrectomy; clinical laboratory to bedside review. Heliyon. 2020;6(2):e03496. doi: https://doi.org/10.1016/j.heliyon.2020.e03496</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res. 2012;61(8):789-807. doi: https://doi.org/10.1007/s00011-012-0473-3</mixed-citation><mixed-citation xml:lang="en">Rao SR. Inflammatory markers and bariatric surgery: a meta-analysis. Inflamm Res. 2012;61(8):789-807. doi: https://doi.org/10.1007/s00011-012-0473-3</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tabasi M, Ashrafian F, Khezerloo JK, et al. Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review. Obes Surg. 2019;29(5):1663-1674. doi: https://doi.org/10.1007/s11695-019-03779-7</mixed-citation><mixed-citation xml:lang="en">Tabasi M, Ashrafian F, Khezerloo JK, et al. Changes in Gut Microbiota and Hormones After Bariatric Surgery: a Bench-to-Bedside Review. Obes Surg. 2019;29(5):1663-1674. doi: https://doi.org/10.1007/s11695-019-03779-7</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Roth AE, Thornley CJ, Blackstone RP. Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review. Curr Obes Rep. 2020;9(3):380-389. doi: https://doi.org/10.1007/s13679-020-00389-8</mixed-citation><mixed-citation xml:lang="en">Roth AE, Thornley CJ, Blackstone RP. Outcomes in Bariatric and Metabolic Surgery: an Updated 5-Year Review. Curr Obes Rep. 2020;9(3):380-389. doi: https://doi.org/10.1007/s13679-020-00389-8</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">King WC, Hinerman AS, Belle SH, et al. Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes. JAMA. 2018;320(15):1560. doi: https://doi.org/10.1001/jama.2018.14433</mixed-citation><mixed-citation xml:lang="en">King WC, Hinerman AS, Belle SH, et al. Comparison of the Performance of Common Measures of Weight Regain After Bariatric Surgery for Association With Clinical Outcomes. JAMA. 2018;320(15):1560. doi: https://doi.org/10.1001/jama.2018.14433</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Brethauer SA, Aminian A, Romero-Talamás H, et al. Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus. Ann Surg. 2013;258(4):628-637. doi: https://doi.org/10.1097/SLA.0b013e3182a5034b</mixed-citation><mixed-citation xml:lang="en">Brethauer SA, Aminian A, Romero-Talamás H, et al. Can Diabetes Be Surgically Cured? Long-Term Metabolic Effects of Bariatric Surgery in Obese Patients with Type 2 Diabetes Mellitus. Ann Surg. 2013;258(4):628-637. doi: https://doi.org/10.1097/SLA.0b013e3182a5034b</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Nedelcu M, Khwaja HA, Rogula TG. Weight regain after bariatric surgery—how should it be defined? Surg Obes Relat Dis. 2016;12(5):1129-1130. doi: https://doi.org/10.1016/j.soard.2016.04.028</mixed-citation><mixed-citation xml:lang="en">Nedelcu M, Khwaja HA, Rogula TG. Weight regain after bariatric surgery—how should it be defined? Surg Obes Relat Dis. 2016;12(5):1129-1130. doi: https://doi.org/10.1016/j.soard.2016.04.028</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Lauti M, Kularatna M, Hill AG, MacCormick AD. Weight Regain Following Sleeve Gastrectomy—a Systematic Review. Obes Surg. 2016;26(6):1326-1334. doi: https://doi.org/10.1007/s11695-016-2152-x</mixed-citation><mixed-citation xml:lang="en">Lauti M, Kularatna M, Hill AG, MacCormick AD. Weight Regain Following Sleeve Gastrectomy—a Systematic Review. Obes Surg. 2016;26(6):1326-1334. doi: https://doi.org/10.1007/s11695-016-2152-x</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Braghetto I, Csendes A, Lanzarini E, et al. Is Laparoscopic Sleeve Gastrectomy an Acceptable Primary Bariatric Procedure in Obese Patients? Early and 5-Year Postoperative Results. Surg Laparosc Endosc Percutan Tech. 2012;22(6):479-486. doi: https://doi.org/10.1097/SLE.0b013e318262dc29</mixed-citation><mixed-citation xml:lang="en">Braghetto I, Csendes A, Lanzarini E, et al. Is Laparoscopic Sleeve Gastrectomy an Acceptable Primary Bariatric Procedure in Obese Patients? Early and 5-Year Postoperative Results. Surg Laparosc Endosc Percutan Tech. 2012;22(6):479-486. doi: https://doi.org/10.1097/SLE.0b013e318262dc29</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Shantavasinkul PC, Omotosho P, Corsino L, et al. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2016;12(9):1640-1645. doi: https://doi.org/10.1016/j.soard.2016.08.028</mixed-citation><mixed-citation xml:lang="en">Shantavasinkul PC, Omotosho P, Corsino L, et al. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2016;12(9):1640-1645. doi: https://doi.org/10.1016/j.soard.2016.08.028</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Baig SJ, Priya P, Mahawar KK, Shah S. Weight Regain After Bariatric Surgery—A Multicentre Study of 9617 Patients from Indian Bariatric Surgery Outcome Reporting Group. Obes Surg. 2019;29(5):1583-1592. doi: https://doi.org/10.1007/s11695-019-03734-6</mixed-citation><mixed-citation xml:lang="en">Baig SJ, Priya P, Mahawar KK, Shah S. Weight Regain After Bariatric Surgery—A Multicentre Study of 9617 Patients from Indian Bariatric Surgery Outcome Reporting Group. Obes Surg. 2019;29(5):1583-1592. doi: https://doi.org/10.1007/s11695-019-03734-6</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Courcoulas AP, King WC, Belle SH, et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018;153(5):427. doi: https://doi.org/10.1001/jamasurg.2017.5025</mixed-citation><mixed-citation xml:lang="en">Courcoulas AP, King WC, Belle SH, et al. Seven-Year Weight Trajectories and Health Outcomes in the Longitudinal Assessment of Bariatric Surgery (LABS) Study. JAMA Surg. 2018;153(5):427. doi: https://doi.org/10.1001/jamasurg.2017.5025</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N Engl J Med. 2004;351(26):2683-2693. doi: https://doi.org/10.1056/NEJMoa035622</mixed-citation><mixed-citation xml:lang="en">Sjöström L, Lindroos A-K, Peltonen M, et al. Lifestyle, Diabetes, and Cardiovascular Risk Factors 10 Years after Bariatric Surgery. N Engl J Med. 2004;351(26):2683-2693. doi: https://doi.org/10.1056/NEJMoa035622</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Ra D, Zeina AR, Sakran N. A Rare Case of Gastrocolic Fistula Secondary to Marginal Ulcer Following Mini Gastric Bypass. Int J Case Rep Clin Image. 2021;3(2):150.</mixed-citation><mixed-citation xml:lang="en">Ra D, Zeina AR, Sakran N. A Rare Case of Gastrocolic Fistula Secondary to Marginal Ulcer Following Mini Gastric Bypass. Int J Case Rep Clin Image. 2021;3(2):150.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ashrafian H, le Roux CW. Metabolic surgery and gut hormones – A review of bariatric entero-humoral modulation. Physiol Behav. 2009;97(5):620-631. doi: https://doi.org/10.1016/j.physbeh.2009.03.012</mixed-citation><mixed-citation xml:lang="en">Ashrafian H, le Roux CW. Metabolic surgery and gut hormones – A review of bariatric entero-humoral modulation. Physiol Behav. 2009;97(5):620-631. doi: https://doi.org/10.1016/j.physbeh.2009.03.012</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ionut V, Burch M, Youdim A, Bergman RN. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity. 2013;21(6):1093-1103. doi: https://doi.org/10.1002/oby.20364</mixed-citation><mixed-citation xml:lang="en">Ionut V, Burch M, Youdim A, Bergman RN. Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity. 2013;21(6):1093-1103. doi: https://doi.org/10.1002/oby.20364</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Demerdash HM, Sabry AA, Arida EA. Role of serotonin hormone in weight regain after sleeve gastrectomy. Scand J Clin Lab Invest. 2018;78(1-2):68-73. doi: https://doi.org/10.1080/00365513.2017.1413714</mixed-citation><mixed-citation xml:lang="en">Demerdash HM, Sabry AA, Arida EA. Role of serotonin hormone in weight regain after sleeve gastrectomy. Scand J Clin Lab Invest. 2018;78(1-2):68-73. doi: https://doi.org/10.1080/00365513.2017.1413714</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Abrahamsson N, Börjesson JL, Sundbom M, et al. Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia. Diabetes. 2016;65(9):2667-2675. doi: https://doi.org/10.2337/db16-0341</mixed-citation><mixed-citation xml:lang="en">Abrahamsson N, Börjesson JL, Sundbom M, et al. Gastric Bypass Reduces Symptoms and Hormonal Responses in Hypoglycemia. Diabetes. 2016;65(9):2667-2675. doi: https://doi.org/10.2337/db16-0341</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Alvarez V, Carrasco F, Cuevas A, et al. Mechanisms of long-term weight regain in patients undergoing sleeve gastrectomy. Nutrition. 2016;32(3):303-308. doi: https://doi.org/10.1016/j.nut.2015.08.023</mixed-citation><mixed-citation xml:lang="en">Alvarez V, Carrasco F, Cuevas A, et al. Mechanisms of long-term weight regain in patients undergoing sleeve gastrectomy. Nutrition. 2016;32(3):303-308. doi: https://doi.org/10.1016/j.nut.2015.08.023</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Maleckas A, Gudaitytė R, Petereit R, et al. Weight regain after gastric bypass: etiology and treatment options. Gland Surg. 2016;5(6):617-624. doi: https://doi.org/10.21037/gs.2016.12.02</mixed-citation><mixed-citation xml:lang="en">Maleckas A, Gudaitytė R, Petereit R, et al. Weight regain after gastric bypass: etiology and treatment options. Gland Surg. 2016;5(6):617-624. doi: https://doi.org/10.21037/gs.2016.12.02</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Knuth ND, Johannsen DL, Tamboli RA, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity. 2014;22(12):2563-2569 doi: https://doi.org/10.1002/oby.20900</mixed-citation><mixed-citation xml:lang="en">Knuth ND, Johannsen DL, Tamboli RA, et al. Metabolic adaptation following massive weight loss is related to the degree of energy imbalance and changes in circulating leptin. Obesity. 2014;22(12):2563-2569 doi: https://doi.org/10.1002/oby.20900</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kalinowski P, Paluszkiewicz R, Wróblewski T, et al. Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial. Surg Obes Relat Dis. 2017;13(2):181-188. doi: https://doi.org/10.1016/j.soard.2016.08.025</mixed-citation><mixed-citation xml:lang="en">Kalinowski P, Paluszkiewicz R, Wróblewski T, et al. Ghrelin, leptin, and glycemic control after sleeve gastrectomy versus Roux-en-Y gastric bypass—results of a randomized clinical trial. Surg Obes Relat Dis. 2017;13(2):181-188. doi: https://doi.org/10.1016/j.soard.2016.08.025</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Ma X, Lin L, Yue J, et al. Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutr Diabetes. 2013;3(12):e99-e99. doi: https://doi.org/10.1038/nutd.2013.41</mixed-citation><mixed-citation xml:lang="en">Ma X, Lin L, Yue J, et al. Ghrelin receptor regulates HFCS-induced adipose inflammation and insulin resistance. Nutr Diabetes. 2013;3(12):e99-e99. doi: https://doi.org/10.1038/nutd.2013.41</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Yu Z, Lowndes J, Rippe J. High-fructose corn syrup and sucrose have equivalent effects on energy-regulating hormones at normal human consumption levels. Nutr Res. 2013;33(12):1043-1052. doi: https://doi.org/10.1016/j.nutres.2013.07.020</mixed-citation><mixed-citation xml:lang="en">Yu Z, Lowndes J, Rippe J. High-fructose corn syrup and sucrose have equivalent effects on energy-regulating hormones at normal human consumption levels. Nutr Res. 2013;33(12):1043-1052. doi: https://doi.org/10.1016/j.nutres.2013.07.020</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Gower BA, Goss AM. A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes. J Nutr. 2015;145(1):177S-183S. doi: https://doi.org/10.3945/jn.114.195065</mixed-citation><mixed-citation xml:lang="en">Gower BA, Goss AM. A Lower-Carbohydrate, Higher-Fat Diet Reduces Abdominal and Intermuscular Fat and Increases Insulin Sensitivity in Adults at Risk of Type 2 Diabetes. J Nutr. 2015;145(1):177S-183S. doi: https://doi.org/10.3945/jn.114.195065</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Stanhope KL, Havel PJ. Fructose Consumption: Considerations for Future Research on Its Effects on Adipose Distribution, Lipid Metabolism, and Insulin Sensitivity in Humans. J Nutr. 2009;139(6):1236S-1241S. doi: https://doi.org/10.3945/jn.109.106641</mixed-citation><mixed-citation xml:lang="en">Stanhope KL, Havel PJ. Fructose Consumption: Considerations for Future Research on Its Effects on Adipose Distribution, Lipid Metabolism, and Insulin Sensitivity in Humans. J Nutr. 2009;139(6):1236S-1241S. doi: https://doi.org/10.3945/jn.109.106641</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Mooren FC, Krüger K, Völker K, et al. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes, Obes Metab. 2011;13(3):281-284. doi: https://doi.org/10.1111/j.1463-1326.2010.01332.x</mixed-citation><mixed-citation xml:lang="en">Mooren FC, Krüger K, Völker K, et al. Oral magnesium supplementation reduces insulin resistance in non-diabetic subjects - a double-blind, placebo-controlled, randomized trial. Diabetes, Obes Metab. 2011;13(3):281-284. doi: https://doi.org/10.1111/j.1463-1326.2010.01332.x</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Wang J, Persuitte G, Olendzki B, et al. Dietary Magnesium Intake Improves Insulin Resistance among Non-Diabetic Individuals with Metabolic Syndrome Participating in a Dietary Trial. Nutrients. 2013;5(10):3910-3919. doi: https://doi.org/10.3390/nu5103910</mixed-citation><mixed-citation xml:lang="en">Wang J, Persuitte G, Olendzki B, et al. Dietary Magnesium Intake Improves Insulin Resistance among Non-Diabetic Individuals with Metabolic Syndrome Participating in a Dietary Trial. Nutrients. 2013;5(10):3910-3919. doi: https://doi.org/10.3390/nu5103910</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Liu C-Y, Huang C-J, Huang L-H, et al. Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, DoubleBlinded, and Placebo-Controlled Trial. PLoS One. 2014;9(3):e91163. doi: https://doi.org/10.1371/journal.pone.0091163</mixed-citation><mixed-citation xml:lang="en">Liu C-Y, Huang C-J, Huang L-H, et al. Effects of Green Tea Extract on Insulin Resistance and Glucagon-Like Peptide 1 in Patients with Type 2 Diabetes and Lipid Abnormalities: A Randomized, DoubleBlinded, and Placebo-Controlled Trial. PLoS One. 2014;9(3):e91163. doi: https://doi.org/10.1371/journal.pone.0091163</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Liu K, Zhou R, Wang B, et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. 2013;98(2):340-348. doi: https://doi.org/10.3945/ajcn.112.052746</mixed-citation><mixed-citation xml:lang="en">Liu K, Zhou R, Wang B, et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr. 2013;98(2):340-348. doi: https://doi.org/10.3945/ajcn.112.052746</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">McLaughlin JT, Lomax RB, Hall L, et al. Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca 2+ -dependent mechanism in the enteroendocrine cell line STC-1. J Physiol. 1998;513(1):11-18. doi: https://doi.org/10.1111/j.1469-7793.1998.011by.x</mixed-citation><mixed-citation xml:lang="en">McLaughlin JT, Lomax RB, Hall L, et al. Fatty acids stimulate cholecystokinin secretion via an acyl chain length-specific, Ca 2+ -dependent mechanism in the enteroendocrine cell line STC-1. J Physiol. 1998;513(1):11-18. doi: https://doi.org/10.1111/j.1469-7793.1998.011by.x</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Ellulu MS, Khaza’ai H, Patimah I, et al. Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Food Nutr Res. 2016;60(1):29268. doi: https://doi.org/10.3402/fnr.v60.29268</mixed-citation><mixed-citation xml:lang="en">Ellulu MS, Khaza’ai H, Patimah I, et al. Effect of long chain omega-3 polyunsaturated fatty acids on inflammation and metabolic markers in hypertensive and/or diabetic obese adults: a randomized controlled trial. Food Nutr Res. 2016;60(1):29268. doi: https://doi.org/10.3402/fnr.v60.29268</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Huerta AE, Navas-Carretero S, Prieto-Hontoria PL, et al. Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity. 2015;23(2):313-321. doi: https://doi.org/10.1002/oby.20966</mixed-citation><mixed-citation xml:lang="en">Huerta AE, Navas-Carretero S, Prieto-Hontoria PL, et al. Effects of α-lipoic acid and eicosapentaenoic acid in overweight and obese women during weight loss. Obesity. 2015;23(2):313-321. doi: https://doi.org/10.1002/oby.20966</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Tomioka H, Masuda J, Takada A, Iwanami A. Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender. Food Nutr Sci. 2020;11(06):431-441. doi: https://doi.org/10.4236/fns.2020.116031</mixed-citation><mixed-citation xml:lang="en">Tomioka H, Masuda J, Takada A, Iwanami A. Differences of Plasma Levels of Tryptophan, Serotonin, 5-Hydroxyindole Acetic Acid, and Kynurenine between Healthy People and Patients of Major Monopolar Depression at Various Age and Gender. Food Nutr Sci. 2020;11(06):431-441. doi: https://doi.org/10.4236/fns.2020.116031</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Taylor Levine M, Gao J, Satyanarayanan SK, et al. S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations. Brain Behav Immun. 2020;85:152-161. doi: https://doi.org/10.1016/j.bbi.2019.07.013</mixed-citation><mixed-citation xml:lang="en">Taylor Levine M, Gao J, Satyanarayanan SK, et al. S-adenosyl-l-methionine (SAMe), cannabidiol (CBD), and kratom in psychiatric disorders: Clinical and mechanistic considerations. Brain Behav Immun. 2020;85:152-161. doi: https://doi.org/10.1016/j.bbi.2019.07.013</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020;22(1):181. doi: https://doi.org/10.3390/ijms22010181</mixed-citation><mixed-citation xml:lang="en">Maffei ME. 5-Hydroxytryptophan (5-HTP): Natural Occurrence, Analysis, Biosynthesis, Biotechnology, Physiology and Toxicology. Int J Mol Sci. 2020;22(1):181. doi: https://doi.org/10.3390/ijms22010181</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">González M, Rodríguez J, Rocha C, et al. Metabolic Correction and Depression: Effect of a Supplement Combination. Ciencias de la Conducta. 2020;35(1):19-36.</mixed-citation><mixed-citation xml:lang="en">González M, Rodríguez J, Rocha C, et al. Metabolic Correction and Depression: Effect of a Supplement Combination. Ciencias de la Conducta. 2020;35(1):19-36.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16(1):14. doi: https://doi.org/10.1186/s12991-017-0138-2</mixed-citation><mixed-citation xml:lang="en">Wallace CJK, Milev R. The effects of probiotics on depressive symptoms in humans: a systematic review. Ann Gen Psychiatry. 2017;16(1):14. doi: https://doi.org/10.1186/s12991-017-0138-2</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Sudsuang R, Chentanez V, Veluvan K. Effect of buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiol Behav. 1991;50(3):543-548. doi: https://doi.org/10.1016/0031-9384(91)90543-W</mixed-citation><mixed-citation xml:lang="en">Sudsuang R, Chentanez V, Veluvan K. Effect of buddhist meditation on serum cortisol and total protein levels, blood pressure, pulse rate, lung volume and reaction time. Physiol Behav. 1991;50(3):543-548. doi: https://doi.org/10.1016/0031-9384(91)90543-W</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Dalkner N, Platzer M, Bengesser SA, et al. The role of tryptophan metabolism and food craving in the relationship between obesity and bipolar disorder. Clin Nutr. 2018;37(5):1744-1751. doi: https://doi.org/10.1016/j.clnu.2017.06.024</mixed-citation><mixed-citation xml:lang="en">Dalkner N, Platzer M, Bengesser SA, et al. The role of tryptophan metabolism and food craving in the relationship between obesity and bipolar disorder. Clin Nutr. 2018;37(5):1744-1751. doi: https://doi.org/10.1016/j.clnu.2017.06.024</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Singh K. Nutrient and Stress Management. J Nutr Food Sci. 2016;6(4):528. doi: https://doi.org/10.4172/2155-9600.1000528</mixed-citation><mixed-citation xml:lang="en">Singh K. Nutrient and Stress Management. J Nutr Food Sci. 2016;6(4):528. doi: https://doi.org/10.4172/2155-9600.1000528</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Sansone RA, Sansone LA. Sunshine, serotonin, and skin: a partial explanation for seasonal patterns in psychopathology? Innov Clin Neurosci. 2013;10(7-8):20-24.</mixed-citation><mixed-citation xml:lang="en">Sansone RA, Sansone LA. Sunshine, serotonin, and skin: a partial explanation for seasonal patterns in psychopathology? Innov Clin Neurosci. 2013;10(7-8):20-24.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Daud NM, Ismail NA, Thomas EL, et al. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity. 2014;22(6):1430-1438. doi: https://doi.org/10.1002/oby.20754</mixed-citation><mixed-citation xml:lang="en">Daud NM, Ismail NA, Thomas EL, et al. The impact of oligofructose on stimulation of gut hormones, appetite regulation and adiposity. Obesity. 2014;22(6):1430-1438. doi: https://doi.org/10.1002/oby.20754</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Horner K, Hopkins M, Finlayson G, et al. Biomarkers of appetite: is there a potential role for metabolomics? Nutr Res Rev. 2020;33(2):271-286. doi: https://doi.org/10.1017/S0954422420000062</mixed-citation><mixed-citation xml:lang="en">Horner K, Hopkins M, Finlayson G, et al. Biomarkers of appetite: is there a potential role for metabolomics? Nutr Res Rev. 2020;33(2):271-286. doi: https://doi.org/10.1017/S0954422420000062</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol. 2014;817:195-219. doi: https://doi.org/10.1007/978-1-4939-0897-4_9</mixed-citation><mixed-citation xml:lang="en">Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol. 2014;817:195-219. doi: https://doi.org/10.1007/978-1-4939-0897-4_9</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kalam F, Gabel K, Cienfuegos S, et al. Changes in Body Weight in Relation to Appetite During 6 Months of Alternate Day Fasting with a Low Carbohydrate Diet. Curr Dev Nutr. 2020;4(S2):1646-1646. doi: https://doi.org/10.1093/cdn/nzaa063_044</mixed-citation><mixed-citation xml:lang="en">Kalam F, Gabel K, Cienfuegos S, et al. Changes in Body Weight in Relation to Appetite During 6 Months of Alternate Day Fasting with a Low Carbohydrate Diet. Curr Dev Nutr. 2020;4(S2):1646-1646. doi: https://doi.org/10.1093/cdn/nzaa063_044</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Deemer SE, Plaisance EP, Martins C. Impact of ketosis on appetite regulation—a review. Nutr Res. 2020;77:1-11. doi: https://doi.org/10.1016/j.nutres.2020.02.010</mixed-citation><mixed-citation xml:lang="en">Deemer SE, Plaisance EP, Martins C. Impact of ketosis on appetite regulation—a review. Nutr Res. 2020;77:1-11. doi: https://doi.org/10.1016/j.nutres.2020.02.010</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Hira T, Pinyo J, Hara H. What Is GLP-1 Really Doing in Obesity? Trends Endocrinol Metab. 2020;31(2):71-80. doi: https://doi.org/10.1016/j.tem.2019.09.003</mixed-citation><mixed-citation xml:lang="en">Hira T, Pinyo J, Hara H. What Is GLP-1 Really Doing in Obesity? Trends Endocrinol Metab. 2020;31(2):71-80. doi: https://doi.org/10.1016/j.tem.2019.09.003</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Jones S, Luo S, Dorton HM, et al. Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior. Front Endocrinol (Lausanne). 2021;12:197. doi: https://doi.org/10.3389/fendo.2021.638504</mixed-citation><mixed-citation xml:lang="en">Jones S, Luo S, Dorton HM, et al. Obesity and Dietary Added Sugar Interact to Affect Postprandial GLP-1 and Its Relationship to Striatal Responses to Food Cues and Feeding Behavior. Front Endocrinol (Lausanne). 2021;12:197. doi: https://doi.org/10.3389/fendo.2021.638504</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Chopra S, Sharma KA, Ranjan P, et al. Weight management module for perimenopausal women: A practical guide for gynecologists. J Midlife Health. 2019;10(4):165. doi: https://doi.org/10.4103/jmh.JMH_155_19</mixed-citation><mixed-citation xml:lang="en">Chopra S, Sharma KA, Ranjan P, et al. Weight management module for perimenopausal women: A practical guide for gynecologists. J Midlife Health. 2019;10(4):165. doi: https://doi.org/10.4103/jmh.JMH_155_19</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Geiker NRW, Astrup A, Hjorth MF, et al. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes Rev. 2018;19(1):81-97. doi: https://doi.org/10.1111/obr.12603</mixed-citation><mixed-citation xml:lang="en">Geiker NRW, Astrup A, Hjorth MF, et al. Does stress influence sleep patterns, food intake, weight gain, abdominal obesity and weight loss interventions and vice versa? Obes Rev. 2018;19(1):81-97. doi: https://doi.org/10.1111/obr.12603</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Zalesin KC, Franklin BA, Miller WM, et al. Preventing Weight Regain After Bariatric Surgery: An Overview of Lifestyle and Psychosocial Modulators. Am J Lifestyle Med. 2010;4(2):113-120. doi: https://doi.org/10.1177/1559827609351227</mixed-citation><mixed-citation xml:lang="en">Zalesin KC, Franklin BA, Miller WM, et al. Preventing Weight Regain After Bariatric Surgery: An Overview of Lifestyle and Psychosocial Modulators. Am J Lifestyle Med. 2010;4(2):113-120. doi: https://doi.org/10.1177/1559827609351227</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Rusch MD, Andris D. Maladaptive Eating Patterns After Weight-Loss Surgery. Nutr Clin Pract. 2007;22(1):41-49. doi: https://doi.org/10.1177/011542650702200141</mixed-citation><mixed-citation xml:lang="en">Rusch MD, Andris D. Maladaptive Eating Patterns After Weight-Loss Surgery. Nutr Clin Pract. 2007;22(1):41-49. doi: https://doi.org/10.1177/011542650702200141</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">El Ansari W, El-Ansari K. Missing Something? Comparisons of Effectiveness and Outcomes of Bariatric Surgery Procedures and Their Preferred Reporting: Refining the Evidence Base. Obes Surg. 2020;30(8):3167-3177. doi: https://doi.org/10.1007/s11695-020-04659-1</mixed-citation><mixed-citation xml:lang="en">El Ansari W, El-Ansari K. Missing Something? Comparisons of Effectiveness and Outcomes of Bariatric Surgery Procedures and Their Preferred Reporting: Refining the Evidence Base. Obes Surg. 2020;30(8):3167-3177. doi: https://doi.org/10.1007/s11695-020-04659-1</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Freire RH, Borges MC, Alvarez-Leite JI, Correia MITD. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28(1):53-58. doi: https://doi.org/10.1016/j.nut.2011.01.011</mixed-citation><mixed-citation xml:lang="en">Freire RH, Borges MC, Alvarez-Leite JI, Correia MITD. Food quality, physical activity, and nutritional follow-up as determinant of weight regain after Roux-en-Y gastric bypass. Nutrition. 2012;28(1):53-58. doi: https://doi.org/10.1016/j.nut.2011.01.011</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Magro DO, Geloneze B, Delfini R, et al. Long-term Weight Regain after Gastric Bypass: A 5-year Prospective Study. Obes Surg. 2008;18(6):648-651. doi: https://doi.org/10.1007/s11695-007-9265-1</mixed-citation><mixed-citation xml:lang="en">Magro DO, Geloneze B, Delfini R, et al. Long-term Weight Regain after Gastric Bypass: A 5-year Prospective Study. Obes Surg. 2008;18(6):648-651. doi: https://doi.org/10.1007/s11695-007-9265-1</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Rosenberger PH, Henderson KE, White MA, et al. Physical Activity in Gastric Bypass Patients: Associations with Weight Loss and Psychosocial Functioning at 12-Month Follow-Up. Obes Surg. 2011;21(10):1564-1569. doi: https://doi.org/10.1007/s11695-010-0283-z</mixed-citation><mixed-citation xml:lang="en">Rosenberger PH, Henderson KE, White MA, et al. Physical Activity in Gastric Bypass Patients: Associations with Weight Loss and Psychosocial Functioning at 12-Month Follow-Up. Obes Surg. 2011;21(10):1564-1569. doi: https://doi.org/10.1007/s11695-010-0283-z</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Livhits M, Mercado C, Yermilov I, et al. Exercise Following Bariatric Surgery: Systematic Review. Obes Surg. 2010;20(5):657-665. doi: https://doi.org/10.1007/s11695-010-0096-0</mixed-citation><mixed-citation xml:lang="en">Livhits M, Mercado C, Yermilov I, et al. Exercise Following Bariatric Surgery: Systematic Review. Obes Surg. 2010;20(5):657-665. doi: https://doi.org/10.1007/s11695-010-0096-0</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Bond DS, Thomas JG, Unick JL, et al. Self-reported and objectively measured sedentary behavior in bariatric surgery candidates. Surg Obes Relat Dis. 2013;9(1):123-128. doi: https://doi.org/10.1016/j.soard.2012.09.008</mixed-citation><mixed-citation xml:lang="en">Bond DS, Thomas JG, Unick JL, et al. Self-reported and objectively measured sedentary behavior in bariatric surgery candidates. Surg Obes Relat Dis. 2013;9(1):123-128. doi: https://doi.org/10.1016/j.soard.2012.09.008</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Goedecke JH, Micklesfield LK. The Effect of Exercise on Obesity, Body Fat Distribution and Risk for Type 2 Diabetes. Medicine and Sport Science. 2014;60:82-93. doi: https://doi.org/10.1159/000357338</mixed-citation><mixed-citation xml:lang="en">Goedecke JH, Micklesfield LK. The Effect of Exercise on Obesity, Body Fat Distribution and Risk for Type 2 Diabetes. Medicine and Sport Science. 2014;60:82-93. doi: https://doi.org/10.1159/000357338</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Panosian J, Ding S-A, Wewalka M, et al. Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management. Am J Med. 2017;130(1):83-92. doi: https://doi.org/10.1016/j.amjmed.2016.07.019</mixed-citation><mixed-citation xml:lang="en">Panosian J, Ding S-A, Wewalka M, et al. Physical Activity in Obese Type 2 Diabetes After Gastric Bypass or Medical Management. Am J Med. 2017;130(1):83-92. doi: https://doi.org/10.1016/j.amjmed.2016.07.019</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Coleman KJ, Caparosa SL, Nichols JF, et al. Understanding the Capacity for Exercise in Post-Bariatric Patients. Obes Surg. 2017;27(1):51-58. doi: https://doi.org/10.1007/s11695-016-2240-y</mixed-citation><mixed-citation xml:lang="en">Coleman KJ, Caparosa SL, Nichols JF, et al. Understanding the Capacity for Exercise in Post-Bariatric Patients. Obes Surg. 2017;27(1):51-58. doi: https://doi.org/10.1007/s11695-016-2240-y</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Creel DB, Schuh LM, Reed CA, et al. A randomized trial comparing two interventions to increase physical activity among patients undergoing bariatric surgery. Obesity. 2016;24(8):1660-1668. doi: https://doi.org/10.1002/oby.21548</mixed-citation><mixed-citation xml:lang="en">Creel DB, Schuh LM, Reed CA, et al. A randomized trial comparing two interventions to increase physical activity among patients undergoing bariatric surgery. Obesity. 2016;24(8):1660-1668. doi: https://doi.org/10.1002/oby.21548</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Rutledge T, Groesz LM, Savu M. Psychiatric Factors and Weight Loss Patterns Following Gastric Bypass Surgery in a Veteran Population. Obes Surg. 2011;21(1):29-35. doi: https://doi.org/10.1007/s11695-009-9923-6</mixed-citation><mixed-citation xml:lang="en">Rutledge T, Groesz LM, Savu M. Psychiatric Factors and Weight Loss Patterns Following Gastric Bypass Surgery in a Veteran Population. Obes Surg. 2011;21(1):29-35. doi: https://doi.org/10.1007/s11695-009-9923-6</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Kheirvari M, Anbara T. Changes in clinical depression following Sleeve Gastrectomy. Endocrinol Diabetes Metab. 2021;4(4). doi: https://doi.org/10.1002/edm2.282</mixed-citation><mixed-citation xml:lang="en">Kheirvari M, Anbara T. Changes in clinical depression following Sleeve Gastrectomy. Endocrinol Diabetes Metab. 2021;4(4). doi: https://doi.org/10.1002/edm2.282</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Sheets CS, Peat CM, Berg KC, et al. Post-operative Psychosocial Predictors of Outcome in Bariatric Surgery. Obes Surg. 2015;25(2):330-345. doi: https://doi.org/10.1007/s11695-014-1490-9</mixed-citation><mixed-citation xml:lang="en">Sheets CS, Peat CM, Berg KC, et al. Post-operative Psychosocial Predictors of Outcome in Bariatric Surgery. Obes Surg. 2015;25(2):330-345. doi: https://doi.org/10.1007/s11695-014-1490-9</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Gill H, Gill B, El‐Halabi S, et al. Antidepressant Medications and Weight Change: A Narrative Review. Obesity. 2020;28(11):2064-2072. doi: https://doi.org/10.1002/oby.22969</mixed-citation><mixed-citation xml:lang="en">Gill H, Gill B, El‐Halabi S, et al. Antidepressant Medications and Weight Change: A Narrative Review. Obesity. 2020;28(11):2064-2072. doi: https://doi.org/10.1002/oby.22969</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Hawkins M, Leung SE, Lee A, et al. Psychiatric Medication Use and Weight Outcomes One Year After Bariatric Surgery. Psychosomatics. 2020;61(1):56-63. doi: https://doi.org/10.1016/j.psym.2019.10.009</mixed-citation><mixed-citation xml:lang="en">Hawkins M, Leung SE, Lee A, et al. Psychiatric Medication Use and Weight Outcomes One Year After Bariatric Surgery. Psychosomatics. 2020;61(1):56-63. doi: https://doi.org/10.1016/j.psym.2019.10.009</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Redmond IP, Shukla AP, Aronne LJ. Use of Weight Loss Medications in Patients after Bariatric Surgery. Curr Obes Rep. 2021;10(2):81-89. doi: https://doi.org/10.1007/s13679-021-00425-1</mixed-citation><mixed-citation xml:lang="en">Redmond IP, Shukla AP, Aronne LJ. Use of Weight Loss Medications in Patients after Bariatric Surgery. Curr Obes Rep. 2021;10(2):81-89. doi: https://doi.org/10.1007/s13679-021-00425-1</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Istfan NW, Lipartia M, Anderson WA, et al. Approach to the Patient: Management of the Post–Bariatric Surgery Patient With Weight Regain. J Clin Endocrinol Metab. 2021;106(1):251-263. doi: https://doi.org/10.1210/clinem/dgaa702</mixed-citation><mixed-citation xml:lang="en">Istfan NW, Lipartia M, Anderson WA, et al. Approach to the Patient: Management of the Post–Bariatric Surgery Patient With Weight Regain. J Clin Endocrinol Metab. 2021;106(1):251-263. doi: https://doi.org/10.1210/clinem/dgaa702</mixed-citation></citation-alternatives></ref><ref id="cit71"><label>71</label><citation-alternatives><mixed-citation xml:lang="ru">Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/ American College of Endocrinology,. Surg Obes Relat Dis. 2020;16(2):175-247. doi: https://doi.org/10.1016/j.soard.2019.10.025</mixed-citation><mixed-citation xml:lang="en">Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/ American College of Endocrinology,. Surg Obes Relat Dis. 2020;16(2):175-247. doi: https://doi.org/10.1016/j.soard.2019.10.025</mixed-citation></citation-alternatives></ref><ref id="cit72"><label>72</label><citation-alternatives><mixed-citation xml:lang="ru">Jirapinyo P, Thompson AC, Kröner PT, et al. Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes. J Am Coll Surg. 2018;226(3):259-266e1. doi: https://doi.org/10.1016/j.jamcollsurg.2017.12.015</mixed-citation><mixed-citation xml:lang="en">Jirapinyo P, Thompson AC, Kröner PT, et al. Metabolic Effect of Foregut Exclusion Demonstrated by the Impact of Gastrogastric Fistula on Recurrence of Diabetes. J Am Coll Surg. 2018;226(3):259-266e1. doi: https://doi.org/10.1016/j.jamcollsurg.2017.12.015</mixed-citation></citation-alternatives></ref><ref id="cit73"><label>73</label><citation-alternatives><mixed-citation xml:lang="ru">Heneghan HM, Yimcharoen P, Brethauer SA, et al. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis. 2012;8(4):408-415. doi: https://doi.org/10.1016/j.soard.2011.09.010</mixed-citation><mixed-citation xml:lang="en">Heneghan HM, Yimcharoen P, Brethauer SA, et al. Influence of pouch and stoma size on weight loss after gastric bypass. Surg Obes Relat Dis. 2012;8(4):408-415. doi: https://doi.org/10.1016/j.soard.2011.09.010</mixed-citation></citation-alternatives></ref><ref id="cit74"><label>74</label><citation-alternatives><mixed-citation xml:lang="ru">Lauti M, Stevenson S, Hill AG, MacCormick AD. Patient Perspectives About Follow-Up Care and Weight Regain Following Sleeve Gastrectomy. Obes Surg. 2016;26(11):2724-2731. doi: https://doi.org/10.1007/s11695-016-2178-0</mixed-citation><mixed-citation xml:lang="en">Lauti M, Stevenson S, Hill AG, MacCormick AD. Patient Perspectives About Follow-Up Care and Weight Regain Following Sleeve Gastrectomy. Obes Surg. 2016;26(11):2724-2731. doi: https://doi.org/10.1007/s11695-016-2178-0</mixed-citation></citation-alternatives></ref><ref id="cit75"><label>75</label><citation-alternatives><mixed-citation xml:lang="ru">Cambi MPC, Baretta GAP, Magro DDO, et al. Multidisciplinary Approach for Weight Regain—how to Manage this Challenging Condition: an Expert Review. Obes Surg. 2021;31(3):1290-1303. doi: https://doi.org/10.1007/s11695-020-05164-1</mixed-citation><mixed-citation xml:lang="en">Cambi MPC, Baretta GAP, Magro DDO, et al. Multidisciplinary Approach for Weight Regain—how to Manage this Challenging Condition: an Expert Review. Obes Surg. 2021;31(3):1290-1303. doi: https://doi.org/10.1007/s11695-020-05164-1</mixed-citation></citation-alternatives></ref><ref id="cit76"><label>76</label><citation-alternatives><mixed-citation xml:lang="ru">Bulajic M, Vadalà di Prampero SF, Boškoski I, Costamagna G. Endoscopic therapy of weight regain after bariatric surgery. World J Gastrointest Surg. 2021;13(12):1584-1596. doi: https://doi.org/10.4240/wjgs.v13.i12.1584</mixed-citation><mixed-citation xml:lang="en">Bulajic M, Vadalà di Prampero SF, Boškoski I, Costamagna G. Endoscopic therapy of weight regain after bariatric surgery. World J Gastrointest Surg. 2021;13(12):1584-1596. doi: https://doi.org/10.4240/wjgs.v13.i12.1584</mixed-citation></citation-alternatives></ref><ref id="cit77"><label>77</label><citation-alternatives><mixed-citation xml:lang="ru">Himpens J, Coromina L, Verbrugghe A, Cadière G-B. Outcomes of Revisional Procedures for Insufficient Weight Loss or Weight Regain After Roux-En-Y Gastric Bypass. Obes Surg. 2012;22(11):1746-1754. doi: https://doi.org/10.1007/s11695-012-0728-7</mixed-citation><mixed-citation xml:lang="en">Himpens J, Coromina L, Verbrugghe A, Cadière G-B. Outcomes of Revisional Procedures for Insufficient Weight Loss or Weight Regain After Roux-En-Y Gastric Bypass. Obes Surg. 2012;22(11):1746-1754. doi: https://doi.org/10.1007/s11695-012-0728-7</mixed-citation></citation-alternatives></ref><ref id="cit78"><label>78</label><citation-alternatives><mixed-citation xml:lang="ru">Dijkhorst PJ, Boerboom AB, Janssen IMC, et al. Failed Sleeve Gastrectomy: Single Anastomosis Duodenoileal Bypass or Rouxen-Y Gastric Bypass? A Multicenter Cohort Study. Obes Surg. 2018;28(12):3834-3842. doi: https://doi.org/10.1007/s11695-018-3429-z</mixed-citation><mixed-citation xml:lang="en">Dijkhorst PJ, Boerboom AB, Janssen IMC, et al. Failed Sleeve Gastrectomy: Single Anastomosis Duodenoileal Bypass or Rouxen-Y Gastric Bypass? A Multicenter Cohort Study. Obes Surg. 2018;28(12):3834-3842. doi: https://doi.org/10.1007/s11695-018-3429-z</mixed-citation></citation-alternatives></ref><ref id="cit79"><label>79</label><citation-alternatives><mixed-citation xml:lang="ru">Al-Khyatt W, Ryall R, Leeder P, et al. Predictors of Inadequate Weight Loss After Laparoscopic Gastric Bypass for Morbid Obesity. Obes Surg. 2017;27(6):1446-1452. doi: https://doi.org/10.1007/s11695-016-2500-x</mixed-citation><mixed-citation xml:lang="en">Al-Khyatt W, Ryall R, Leeder P, et al. Predictors of Inadequate Weight Loss After Laparoscopic Gastric Bypass for Morbid Obesity. Obes Surg. 2017;27(6):1446-1452. doi: https://doi.org/10.1007/s11695-016-2500-x</mixed-citation></citation-alternatives></ref><ref id="cit80"><label>80</label><citation-alternatives><mixed-citation xml:lang="ru">Anbara T. The effects of age on weight loss after sleeve gastrectomy. Integr J Med Sci. 2021;8. doi: https://doi.org/10.15342/ijms.2021.433</mixed-citation><mixed-citation xml:lang="en">Anbara T. The effects of age on weight loss after sleeve gastrectomy. Integr J Med Sci. 2021;8. doi: https://doi.org/10.15342/ijms.2021.433</mixed-citation></citation-alternatives></ref><ref id="cit81"><label>81</label><citation-alternatives><mixed-citation xml:lang="ru">Ugarte C, Quiñones Á, Vicente B. Predictores psicológicos de la re-ganancia del peso en pacientes bariátricos. Ter psicológica. 2019;37(3):199-209. doi: https://doi.org/10.4067/S0718-48082019000300199</mixed-citation><mixed-citation xml:lang="en">Ugarte C, Quiñones Á, Vicente B. Predictores psicológicos de la re-ganancia del peso en pacientes bariátricos. Ter psicológica. 2019;37(3):199-209. doi: https://doi.org/10.4067/S0718-48082019000300199</mixed-citation></citation-alternatives></ref><ref id="cit82"><label>82</label><citation-alternatives><mixed-citation xml:lang="ru">Yang P-J, Chen C-L, Chen C-N, et al. Early weight loss as a predictor of 3-year weight loss and weight regain in patients with good compliance after sleeve gastrectomy. Surg Obes Relat Dis. 2021;17(8):1418-1423. doi: https://doi.org/10.1016/j.soard.2021.03.023</mixed-citation><mixed-citation xml:lang="en">Yang P-J, Chen C-L, Chen C-N, et al. Early weight loss as a predictor of 3-year weight loss and weight regain in patients with good compliance after sleeve gastrectomy. Surg Obes Relat Dis. 2021;17(8):1418-1423. doi: https://doi.org/10.1016/j.soard.2021.03.023</mixed-citation></citation-alternatives></ref><ref id="cit83"><label>83</label><citation-alternatives><mixed-citation xml:lang="ru">Martin-Fernandez KW, Creel DB, Schuh LM. Psychosocial and behavioral correlates of weight loss 12 to 15 years after bariatric surgery. J Behav Med. 2022;45(2):252-259. doi: https://doi.org/10.1007/s10865-021-00263-5</mixed-citation><mixed-citation xml:lang="en">Martin-Fernandez KW, Creel DB, Schuh LM. Psychosocial and behavioral correlates of weight loss 12 to 15 years after bariatric surgery. J Behav Med. 2022;45(2):252-259. doi: https://doi.org/10.1007/s10865-021-00263-5</mixed-citation></citation-alternatives></ref><ref id="cit84"><label>84</label><citation-alternatives><mixed-citation xml:lang="ru">Smith KR, Aghababian A, Papantoni A, et al. One Year Follow-Up of Taste-Related Reward Associations with Weight Loss Suggests a Critical Time to Mitigate Weight Regain Following Bariatric Surgery. Nutrients. 2021;13(11):3943. doi: https://doi.org/10.3390/nu13113943</mixed-citation><mixed-citation xml:lang="en">Smith KR, Aghababian A, Papantoni A, et al. One Year Follow-Up of Taste-Related Reward Associations with Weight Loss Suggests a Critical Time to Mitigate Weight Regain Following Bariatric Surgery. Nutrients. 2021;13(11):3943. doi: https://doi.org/10.3390/nu13113943</mixed-citation></citation-alternatives></ref><ref id="cit85"><label>85</label><citation-alternatives><mixed-citation xml:lang="ru">Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14(6):741-747. doi: https://doi.org/10.1016/j.soard.2018.02.027</mixed-citation><mixed-citation xml:lang="en">Clapp B, Wynn M, Martyn C, Foster C, O’Dell M, Tyroch A. Long term (7 or more years) outcomes of the sleeve gastrectomy: a meta-analysis. Surg Obes Relat Dis. 2018;14(6):741-747. doi: https://doi.org/10.1016/j.soard.2018.02.027</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
